Category: 1261686-95-6

On June 14, 2018, Andrez, Jean-Christophe; Bogucki, David Earl; Burford, Kristen Nicole; Chowdhury, Sultan; Cohen, Charles Jay; Decker, Shannon Marie; Dehnhardt, Christoph Martin; Devita, Robert Joseph; Empfield, James Roy; Focken, Thilo; Grimwood, Michael Edward; Hasan, Syed Abid; Jia, Qi; Johnson, James Philip, Jr.; Wilson, Michael Scott; Zenova, Alla Yurevna published a patent.Quality Control of 2-(Bromomethyl)-6-fluorobenzonitrile The title of the patent was Preparation of benzenesulfonamides and their use as therapeutic agents. And the patent contained the following:

The invention relates to preparation of benzenesulfonamides of formula I, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy. Compounds I wherein A is a direct bond, R1 is (un)substituted cycloalkyl, aryl, monocyclic heteroaryl, etc.; R2 is (un)substituted 5-membered or 6-membered heteroaryl; R3 is O, S(O)t, etc.; R6 is H, halo, haloalkyl; R7 is alkyl, alkenyl, halo, etc.; q is 1,2 or 3; t is 0, 1 or 2, are claimed. Compounds I were evaluated for their biol. activity in bioassays (data given). Compounds I can be used in the treatment of voltage-gated sodium channel-mediated diseases. The experimental process involved the reaction of 2-(Bromomethyl)-6-fluorobenzonitrile(cas: 1261686-95-6).Quality Control of 2-(Bromomethyl)-6-fluorobenzonitrile

The Article related to benzenesulfonamide preparation sodium channel disease treatment epilepsy, Benzene, Its Derivatives, and Condensed Benzenoid Compounds: Sulfenic, Sulfinic, and Sulfonic Acids and Derivatives and other aspects.Quality Control of 2-(Bromomethyl)-6-fluorobenzonitrile

Referemce:
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

On December 3, 2020, Grosse, Sandrine Celine; Deratt, Lindsey Graham; Vandyck, Koen; Raboisson, Pierre Jean-Marie Bernard; Pieters, Serge Maria Aloyssius; Kesteleyn, Bart Rudolf Romanie; Verschueren, Wim Gaston; Berke, Jan Martin; LeComte, Morgan Charles R.; Martinez Lamenca, Carolina; Jonckers, Tim Hugo Maria; Deng, Gang; Jiang, Yimin; Xu, Yanping; Cheng, Zhangling; Hu, Lili; Kuduk, Scott D. published a patent.COA of Formula: C8H5BrFN The title of the patent was Fused heterocyclic derivatives as antiviral agents and their preparation. And the patent contained the following:

The application describes fused heterocycle derivatives of formula I, pharmaceutical compositions comprising these compounds, chem. processes for preparing these compounds and their use in the treatment of diseases associated with HBV infection. Compounds of formula I wherein A is absent and CH2; X is CH2 and O; Y is NH and derivatives; W is CHR3 and CH:CH2; Z is CO and CS; R1 is (un)substituted 5- to 10-membered (mono/bi)cyclic ring optionally containing heteroatoms; R2 is H and (un)substituted C1-4 alkyl; R3 is H, F, OH, (un)substituted C1-4 alkyl, etc.; and pharmaceutically acceptable salts thereof, are claimed. Example compound II was prepared by cyclization of Et 2-(2-aminoethyl)-5-(3,4-dichlorobenzoyl)-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-3-carboxylate bistrifluoroacetate. The invention compounds were evaluated for their antiviral activity. From the assay, it was determined that compound II exhibited an EC50 value 9.628渭M and a CC50 value of > 50渭M. The experimental process involved the reaction of 2-(Bromomethyl)-6-fluorobenzonitrile(cas: 1261686-95-6).COA of Formula: C8H5BrFN

The Article related to heterocycle preparation antiviral, Heterocyclic Compounds (More Than One Hetero Atom): Pyrazines and Quinoxalines (Including Piperazines) and other aspects.COA of Formula: C8H5BrFN

Referemce:
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

On August 5, 2015, Van Doremaele, Gerard; Berthoud, Alexandra; Quiroga Norambuena, Victor; Rupnicki, Leszek; Karbaum, Peter published a patent.Recommanded Product: 2-(Bromomethyl)-6-fluorobenzonitrile The title of the patent was Metal complex with a cyclic amidine ligand. And the patent contained the following:

The present invention relates to a metal complex, CyYMLjXn (Cy = cyclopentadienyl-type ligand; M = metal of group 4; L = neutral Lewis basic ligand wherein the number of said neutral ligands j = the range of 0 to the amount that satisfies the 18-electron rule; X = anionic ligand; n = integer denoting the number of anionic ligands X and is 1 or 2, preferably is 2; Y = cyclic amidine-containing ligand), wherein the amidine-containing ligand is covalently bonded to the metal M via the imine nitrogen atom. Thus, reaction of 2-cyclopentylisoindolin-1-imine hydrobromide with (C5Me5)3TiCl gave title polymerization catalyst, Me5CpTiCl2(NC(Ph)(c-C5H9N)). The experimental process involved the reaction of 2-(Bromomethyl)-6-fluorobenzonitrile(cas: 1261686-95-6).Recommanded Product: 2-(Bromomethyl)-6-fluorobenzonitrile

The Article related to cyclic amidine titanium preparation polymerization catalyst, Organometallic and Organometalloidal Compounds: Groups Iiib, Ivb, Vb – Sc, Y, Lanthanides, Actinides, Ti, Zr, Hf, V, Nb, Ta and other aspects.Recommanded Product: 2-(Bromomethyl)-6-fluorobenzonitrile

Referemce:
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

On August 6, 2015, Van Doremaele, Gerardus Henricus Josephus; Berthoud, Alexandra; Quiroga Norambuena, Victor; Rupnicki, Leszek; Karbaum, Peter published a patent.Application In Synthesis of 2-(Bromomethyl)-6-fluorobenzonitrile The title of the patent was Metal complex with a cyclic amidine ligand. And the patent contained the following:

The present invention relates to a metal complex, CyYMLjXn (Cy = cyclopentadienyl-type ligand; M = metal of group 4; L = neutral Lewis basic ligand wherein the number of said neutral ligands j = the range of 0 to the amount that satisfies the 18-electron rule; X = anionic ligand; n = integer denoting the number of anionic ligands X and is 1 or 2, preferably is 2; Y = cyclic amidine-containing ligand), wherein the amidine-containing ligand is covalently bonded to the metal M via the imine nitrogen atom. Thus, reaction of 2-cyclopentylisoindolin-1-imine hydrobromide with (C5Me5)3TiCl gave title polymerization catalyst, Me5CpTiCl2(NC(Ph)(c-C5H9N)). The experimental process involved the reaction of 2-(Bromomethyl)-6-fluorobenzonitrile(cas: 1261686-95-6).Application In Synthesis of 2-(Bromomethyl)-6-fluorobenzonitrile

The Article related to cyclic amidine titanium preparation polymerization catalyst, Organometallic and Organometalloidal Compounds: Groups Iiib, Ivb, Vb – Sc, Y, Lanthanides, Actinides, Ti, Zr, Hf, V, Nb, Ta and other aspects.Application In Synthesis of 2-(Bromomethyl)-6-fluorobenzonitrile

Referemce:
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

On June 14, 2018, Andrez, Jean-Christophe; Bogucki, David Earl; Burford, Kristen Nicole; Chowdhury, Sultan; Cohen, Charles Jay; Decker, Shannon Marie; Dehnhardt, Christoph Martin; Devita, Robert Joseph; Empfield, James Roy; Focken, Thilo; Grimwood, Michael Edward; Hasan, Syed Abid; Jia, Qi; Johnson, James Philip, Jr.; Wilson, Michael Scott; Zenova, Alla Yurevna published a patent.Quality Control of 2-(Bromomethyl)-6-fluorobenzonitrile The title of the patent was Preparation of benzenesulfonamides and their use as therapeutic agents. And the patent contained the following:

The invention relates to preparation of benzenesulfonamides of formula I, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy. Compounds I wherein A is a direct bond, R1 is (un)substituted cycloalkyl, aryl, monocyclic heteroaryl, etc.; R2 is (un)substituted 5-membered or 6-membered heteroaryl; R3 is O, S(O)t, etc.; R6 is H, halo, haloalkyl; R7 is alkyl, alkenyl, halo, etc.; q is 1,2 or 3; t is 0, 1 or 2, are claimed. Compounds I were evaluated for their biol. activity in bioassays (data given). Compounds I can be used in the treatment of voltage-gated sodium channel-mediated diseases. The experimental process involved the reaction of 2-(Bromomethyl)-6-fluorobenzonitrile(cas: 1261686-95-6).Quality Control of 2-(Bromomethyl)-6-fluorobenzonitrile

The Article related to benzenesulfonamide preparation sodium channel disease treatment epilepsy, Benzene, Its Derivatives, and Condensed Benzenoid Compounds: Sulfenic, Sulfinic, and Sulfonic Acids and Derivatives and other aspects.Quality Control of 2-(Bromomethyl)-6-fluorobenzonitrile

Referemce:
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts